$Features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction$

Features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction

Aim. In order to study the possibilities of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction recent researches on this problem were reviewed. The literatu...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Syvolap, L. V. Lukashenko, S. P. Zhemanyuk, M. P. Gerasko, L. V. Franskyavichene
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2015-12-01
Series:	Zaporožskij Medicinskij Žurnal
Subjects:	Myocardial Infarction Acute Disease Randomized Controlled Trials as Topic Aldosterone
Online Access:	http://zmj.zsmu.edu.ua/article/view/57363/54624
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The use of mineralocorticoid antagonists in chronic heart failure
by: Andrea Szegedi, et al.
Published: (2025-07-01)

Relationship of plasma aldosterone levels and carbohydrate metabolism in heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-02-01)

INFLUENCE OF COMORBIDITIES ON BLOOD ALDOSTERONE LEVEL IN CHRONIC HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION OF THE LEFT VENTRICLE
by: N. T. Vatutin, et al.
Published: (2017-12-01)

The The Impact of Dapagliflozin on Aldosterone Hormone in Rats with Heart Failure
by: Skala Mamand Jawhar, et al.
Published: (2023-09-01)

Relationship between plasma aldosterone and left ventricular structure and function in patients with heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-03-01)

Comparative effects of renin-angiotensin-aldosterone system modulators on right heart function and prognosis in patients with severe systolic chronic heart failure
by: K. G. Adamyan, et al.
Published: (2012-12-01)

Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis
by: Rhys Williams, et al.
Published: (2024-11-01)

Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity
by: S. N. Tereshchenko, et al.
Published: (2009-10-01)

Is there the phenotype of chronic heart failure with “intermediate” left ventricular ejection fraction? Additional echocardiographic criteria for left ventricular systolic dysfunction in patients with chronic heart failure of ischemic origin with ejection fraction in the “gray area”
by: V. V. Syvolap, et al.
Published: (2021-06-01)

The association between aldosterone and lipid profiles in patients with primary aldosteronism
by: Ning-Peng Liang, et al.
Published: (2025-03-01)

ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE
by: V. I. Podzolkov, et al.
Published: (2017-05-01)

Extracellular matrix remodeling in patients with ischemic chronic heart failure with preserved ejection fraction
by: V. D. Syvolap, et al.
Published: (2015-04-01)

CARDIOPROTECTIVE PROPERTIES OF PROGESTINES: INFLUENCE OF DROSPIRENONE ON MYOCARD IN EXPERIMENTAL HEART FAILURE
by: Yu. V. Liskova, et al.
Published: (2017-07-01)

Effect of Age on Aldosterone–Renin Ratio in Screening Primary Aldosteronism
by: Ning Peng, et al.
Published: (2025-03-01)

Influence of aldosterone antagonists on markers of electrophysiological instability in patients with heart failure with mid-range ejection fraction after ST-segment elevation acute coronary syndrome in the short- and long-term periods
by: L. V. Shekhovtsova, et al.
Published: (2020-11-01)

SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper
by: João Pedro Ferreira, et al.
Published: (2025-08-01)

ALDOSTERONE LEVELS AND HEART REMODELING IN MYOCARDIAL INFARCTION PATIENTS WITH NON-DIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA
by: E. P. Miroshnichenko, et al.
Published: (2016-11-01)

Association Between Hyperaldosteronemia and Electrophysiological Myocardial Activity in Heart Failure with Preserved Ejection Fraction
by: A. N. Shevelok
Published: (2020-10-01)

Prognostic values of the diastolic index as a marker of chronic heart failure with preserved left ventricular ejection fraction
by: V. V. Syvolap, et al.
Published: (2024-02-01)

MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
by: V. N. Soboleva, et al.
Published: (2015-01-01)

Plasma Aldosterone Elevation in Hypertensive Patients and Association with Urinary Stone Formation: A Large-Scale Population Study from Northwest China
by: Song S, et al.
Published: (2025-05-01)

The impact of chronic heart failure on heart remodeling in patients with atrial fibrillation
by: V. А. Lysenko, et al.
Published: (2021-07-01)

The effect of aldosterone receptor antagonists on cardiovascular system in maintenance hemodialysis patients
by: JIANG Mei, et al.
Published: (2020-01-01)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021-03-01)

Features of cardiovascular remodeling, the level of neurohumoral factors depending on the degree of chronic heart failure and kidney dysfunction
by: U. K. Kamilova, et al.
Published: (2019-06-01)

Myocardial remodeling and arterial stiffness depending on aldosterone level in patients with chronic kidney disease and arterial hypertension
by: O. V. Kuryata, et al.
Published: (2019-12-01)

Pathology and gene mutations of aldosterone-producing lesions
by: Koshiro Nishimoto, et al.
Published: (2023-12-01)

Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the Treatment
by: Eriko Nakano, et al.
Published: (2025-07-01)

AT II RECEPTOR ANTAGONISTS IN CHRONIC HEART FAILURE TREATMENT
by: M. A. Gurevich
Published: (2009-04-01)

Cardiorenal relationships in patients with chronic heart failure with preserved ejection fraction
by: Yu. N. Panina, et al.
Published: (2023-11-01)

Effect of eplerenone on aldosterone and von Willebrand factor levelsin patients with myocardial infarction and chronic kidney disease
by: V. K. Tashchuk, et al.
Published: (2022-02-01)

Effect of plasma aldosterone concentration on serum uric acid metabolism
by: WEI Yushuang, et al.
Published: (2025-02-01)

Renal Dysfunction in Primary Aldosteronism: How, When, and Who?
by: Michael Kitlinski, et al.
Published: (2025-01-01)

The impact of renal tubulointerstitial dysfunction on the early and long-term prognosis in chronic heart failure patients with preserved left ventricular ejection fraction
by: V. V. Syvolap, et al.
Published: (2024-04-01)

Assessment of the functional state of left heart in patients with chronic heart failure with preserved ejection fraction
by: D. V. Vdovenko, et al.
Published: (2019-03-01)

Elderly men are underscreened for primary aldosteronism even in Hypertension Excellence Centre
by: Avital Angel Korman, et al.
Published: (2024-12-01)

Threonine in different phenotypes of chronic heart failure with preserved ejection fraction
by: Maria F. Petruhnova, et al.
Published: (2024-09-01)

Diagnostic uncertainty in primary aldosteronism
by: Marković Bojan, et al.
Published: (2024-01-01)

Duration of rheumatoid arthritis changes blood levels of angiotensin and aldosterone
by: Boris A. Rebrov, et al.
Published: (2023-12-01)

Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension
by: Nikita Makhnov, et al.
Published: (2025-04-01)